Avista Healthcare Partners and Damier Group have agreed to acquire Sanotact, a German vitamins, minerals, and supplements platform. The deal involves Flotte, Sanotact's existing shareholder, making a significant reinvestment and continuing to support the company's growth. Martin Spengler serves as Sanotact's CEO. No financial terms were disclosed.

This acquisition unites Avista, a healthcare-focused private equity firm, with Damier, the family office of serial entrepreneur Yvan Vindevogel. It targets a company supplying private-label and branded nutritional products, a sector seeing heightened private equity activity due to consistent consumer demand.

The transaction underscores ongoing investor interest in the stable vitamins and supplements market. Flotte's continued involvement signals confidence in Sanotact's management and growth trajectory. The deal positions the combined entity to capitalize on expanding health and wellness trends across Europe.